Screener
GPZ vs BBH
VanEck Alternative Asset Manager ETF vs VanEck Biotech ETF
Key differences
- BBH costs 0.05% less per year.
- BBH has a longer track record, which may reduce uncertainty around long-term behavior.
Side-by-side comparison
| GPZ | BBH | |
|---|---|---|
| Annual cost (TER) | 0.40% | 0.35% |
| Fund size (AUM) | $245M | $365M |
| Since | 2025 | 2011 |
| Dividend yield | — | 0.52% |
| Asset class | equity | equity |
| Region | — | north america |
| Strategy | index tracking | index tracking |
| CAGR 1Y | N/A | +26.8% |
| CAGR 3Y | N/A | +5.9% |
| CAGR 5Y | N/A | +1.2% |
| Sharpe 3Y | N/A | 0.21 |
| Volatility 1Y | — | 18.82% |
| Max drawdown | -31.72% | -39.86% |
Green dot indicates the better value for that metric. Performance data is historical and does not predict future results.
Similar to GPZ and BBH
Explore further